back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-16 13:48 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
Kraws, Jeffrey Jay
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+16,367 vol |
16,367 | |
| Filed 2026-03-16 13:46 Tx date 2025-10-23 |
$VM
Voyageur Pharmaceuticals Ltd. |
Kraws, Jeffrey Jay
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-09 11:22 Tx date 2026-03-04 |
$VM
Voyageur Pharmaceuticals Ltd. |
Hashmi, Ibrahim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
450,000 | |
| Filed 2026-03-08 15:14 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
Alling, Virginia Glasheen
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+9,906 vol |
9,906 | |
| Filed 2026-03-08 15:13 Tx date 2025-11-05 |
$VM
Voyageur Pharmaceuticals Ltd. |
Alling, Virginia Glasheen
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-06 16:59 Tx date 2026-03-04 |
$VM
Voyageur Pharmaceuticals Ltd. |
Deslauriers, Albert Hill
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
1,750,000 | |
| Filed 2026-03-06 16:31 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
McBeth, Kevin Richard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+71,131 vol |
652,181 | |
| Filed 2026-03-06 16:27 Tx date 2026-03-04 |
$VM
Voyageur Pharmaceuticals Ltd. |
Mohan, Ethan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+800,000 vol |
1,800,000 | |
| Filed 2026-03-06 16:23 Tx date 2026-03-04 |
$VM
Voyageur Pharmaceuticals Ltd. |
Willis, William Brent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,100,000 vol |
4,495,000 | |
| Filed 2026-03-06 16:18 Tx date 2026-03-04 |
$VM
Voyageur Pharmaceuticals Ltd. |
Willis, Bradley Craig
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
4,070,000 | |
| Filed 2026-03-06 16:12 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
Gago, Agustin Vicente
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+41,842 vol |
41,842 | |
| Filed 2026-03-06 16:07 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
Van Buren, Christopher Antoine
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+16,367 vol |
16,367 | |
| Filed 2026-03-06 16:06 Tx date 2025-10-23 |
$VM
Voyageur Pharmaceuticals Ltd. |
Van Buren, Christopher Antoine
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-03-06 15:57 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
Shaw, Beth
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+80,776 vol |
90,854 | |
| Filed 2026-03-06 15:53 Tx date 2026-03-04 |
$VM
Voyageur Pharmaceuticals Ltd. |
Saranchova, Iryna Yuriyivna
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
800,000 | |
| Filed 2026-03-06 15:43 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
Pommer, Eric
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+71,131 vol |
958,531 | |
| Filed 2026-03-06 15:36 Tx date 2026-03-03 |
$VM
Voyageur Pharmaceuticals Ltd. |
Fritzel, Eugene Leonard
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Unit
56 - Grant of rights
|
+71,131 vol |
958,531 | |
| Filed 2025-08-20 13:36 Tx date 2025-08-18 |
$VM
Voyageur Pharmaceuticals Ltd. |
Mohan, Ethan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$112,000
+1,120,000 vol $0.10 each |
2,382,857 | |
| Filed 2025-08-20 13:33 Tx date 2025-08-18 |
$VM
Voyageur Pharmaceuticals Ltd. |
Mohan, Ethan
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-1,120,000 vol |
0 | |
| Filed 2025-07-15 18:12 Tx date 2025-07-10 |
$VM
Voyageur Pharmaceuticals Ltd. |
Shaw, Beth
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,500
+100,000 vol $0.195 each |
100,000 |